glp 1 peptides retatrutide new drug GLP-1 obesity drug, retatrutide, shows added benefits Triple Agonist Explained: Retatrutide, – Retatrutide 50mg | High Potency

Another advantage is accessibility

Looking at this, initially there was a key case control study that came out in twenty twenty four, in the journal nature that looked at depression, anxiety and suicidal behavior in patients taking GLP-1 for weight management

Insights into the arginine paradox: evidence against the importance of subcellular location of arginase and eNOS

Preclinical research has examined CJC-1295 No DAC (and related GHRH analogues) in models of skeletal muscle protein synthesis, lean mass accretion, adipose tissue lipolysis, bone mineral density, and collagen synthesis with IGF-1 elevation identified as the primary mediator of these downstream effects